¦V¤W Abnormal Bleeding Endometriosis PID Cervical Pregnancy Amenorrhea Chronic Pelvic Pain Ectopic Pregnancy interstitial pregnancy Periop management Pelvic mass Acute Pelvic Pain Endoscopic Myomectomy Nutritional Support ectopic pregnancy LAVH HRT candidiasis PMS Amenorrhea

~ Amenorrhea ~

¤U¸ü MS Office .doc ÀÉ

¡@

Decision tree for evaluation of amenorrhea

v Classification:

? No menses by 16 y/o with presence of 2o sexual characteristic, or

No visible 2o sexual characteristic by 14 y/o

Absence of menstruation for three normal menstrual cycles or 6 months

¡@

v Work-up for Amenorrhea:

? Hx: G?P?, LMP?, OBS/GYN Hx, medical diseases, operation Hx, etc.

PE, PV, and/or PR:

2o sexual characteristic (breast, pubic hair, axillary hair, etc.)

uterus, cervix, vagina, external genitalia, etc.

ƒ Lab. Survey: EIA, FSH, TSH, PRL, E2, etc.

Image Study: ultrasound, HSG, CT, MRI,etc.

¡@

v Amenorrhea without Secondary Sexual Characteristic:

Abnormal Physical Examination:

5a -reductase deficiency in XY individual

17-20 desmolase deficiency in XY individual (rare)

17a -hydroxylase deficiency in XY individual

Hypergonadotropic Hypogonadism:

(disorders of ovaries, either genetic origin, enzymatic origin, or other origin)

Gonadal dysgenesis (eg. Turner¡¦s syndrome): the most common cause

Pure gonadal dysgenesis

Partial deletion of X chromosome

Sex chromosome mosaicism

Environmental and therapeutic ovarian toxins

17a -hydroxylase deficiency in XX individual

Galactosemia

Others

Hypogonadotropic Hypogonadism:

(disorders of hypothalamic origin or pituitary origin)

Physical delay: the most common cause

Kallman¡¦s syndrome: insufficient pulsatile secretion of GnRH

Central nervous system tumors: most commonly, craniopharyngioma

Hypothalamic/pituitary dysfunction

    1. The FSH level differentiates hypergonadotropic and hypogronadotropic forms of hypogonadism.
    2. See figure 24.1
    1. Generally, estrogen and progestin
    2. ? cyclic:

      premarin (0.625) 0.625 mg qd ´ 25 ds

      provera (5) 5-10 mg qd ´ 12-14 ds

      continuous

    3. for patients with 17a -hydroxylase deficiency:
    4. Add corticosteroid replacement

    5. Specific considerations:

Eg. craniopharyngioma è radiotherapy

`

v Amenorrhea with Secondary Sexual Characteristic

and Anatomic Abnormalities:

Mullerian anomalies:

Imperforate hymen: bulging membrane during valsalva maneuver

Transverse vaginal septum

Mayer-Rokitansky-Kuster-Hauser syndrome:

ie. hypoplasia or absence of the uterus, cervix, and or vagina

PE, ultrasound or MRI, IVP (to detect concomitant renal anomaly)

Androgen insensitivity:

male pseudohermaphrodites, 46XY

absent pubic hair and axillary hair

True hermaphrodites: Both male and female gonadal tissue is present.

Absent endometrium

Asherman¡¦s syndrome: diagnosed by HSG or hysteroscopy

Secondary to prior uterine or cervical surgery

Currettage, especially postpartum

Cone biopsy

Loop electroexcision procedure

Secondary to infections

Pelvic inflammatory disease

IUD-related

Tuberculosis endometrial

Schistosomiasis culture

    1. Imperforate hymen: a cruciate incision to open the vaginal orifice
    2. Transverse septum: surgical removal
    3. Hypoplasia or absence of the cervixa: still no effective way to correct
    4. Absent or short vagina:
    5. progressive dilation, if fails, then McIndoe split thickness graft technique

    6. Complete androgen insensitivity: bilateral laparoscopic gonadectomy
    7. Asherman¡¦s syndrome:

Lysis of adhesion, IUD insertion (or pediatric Foley) 7-10 days post-operatively,

Systemic broad-spectrum antibiotics, 2-month course of high-dose estrogen

¡@

v Amenorrhea with Secondary Sexual Characteristic and Nonanatomic Causes:

    1. Pregnancy
    2. Thyroid dysfuction and hyperprolactinemia
    3. Ovarian Failure:
    4. Genetic disorders: mosaicism of an XO or XY cell line, deletion of a portion of

      X chromosome, 47XXX.

      Iatrogenic causes: radiation, chemotherapy, surgical alteration of ovarian blood supply.

      Infections

      Autoimmune disorders

      Galactosemia (mild form or heterozygote)

      Savage syndrome: FSH receptors are absent or a postreceptor defect exists

      Cigarette smoking

      Idiopathic

    5. Hypothalamic/pituitary lesions:
    6. Hypothalamic/pituitary:

      Craniopharynigioma

      Germinoma

      Tubercular granuloma

      Sarcoid granuloma

      Dermoid cyst

      Pituitary:

      Nonfunctional adenoma

      Hormone-secreting ademonas:

      Prolactinoma

      Cushing¡¦s disease

      Acromegaly

      Primary hyperthyroidism

      Infarction

      Lymphocytic hypophysitis

      Surgical or radiological ablations

      Sheehan¡¦s syndrome: postpartum necrosis of the pituitary

      Diabetic vasculitis

    7. Abnormal hypothalamic GnRH secretion

Variable estrogen status:

Anorexia nervosa

Exercise-induced

Stress-induced

Pseudocyesis

Malnutrition

Chronic diseases:

DM, renal disorders, pulmonary disorders, liver disease,

chronic infections, Addison¡¦s disease

Hyperprolactinemia

Thyroid dysfuction

Euestrogenic states:

Obesity

Hyperandrogenism:

Polycystic ovarian syndrome

Cushing¡¦s syndrome

Congenital adrenal hyperplasia

Androgen-secreting adrenal tumors

Androgen-secreting ovarian tumors

Granulosa cell tumor

Idiopathic

    1. Pregnancy test
    2. Hormone status:
    3. TSH and prolactin levels:

      ¡P If elevated TSH and prolactin level are found, the hypothyroidism

      should be treat before hyperprolactinemia is treated

      FSH level

      Estrogen status: progesterone challenge test

      ¡P Provera (5) 5 or 10 mg for 10 days, or

      ¡P progesterone 100-200 mg im.

    4. Assessment of the hypothalamus and pituitary
    1. estrogen therapy: for protection against cardiac diseases and prevention of osteoporosis
    2. gonadectomy: when Y cell line present
    3. treatment of underlying diseases
    4. treatment for hirsutism:
    5. oral contraceptives: decreasing ovarian androgen production,

      increasing circulating levels of sex hormone-binding globulin

      spironolactone: decreasing androgen production,

      competing with androgen at the androgen-receptor level

    6. for conception: ® ovulation induction

Clomiphene citrate:

The usual first choice

Effective only in patients with adequate levels of estrogen, FSH, and PRL

Contraindications: pregnancy, liver disease, preexisting ovarian cysts.

Dosage: Clomiphene 50 mg qd since D5 for 5 days

HMG:

When clomiphene fails, or hypogonadotropic hypoestrogenic anovulation

GnRH:

Effective in patients with low level of estrogen and gonadotropins

Filename: Amenorrhea

¡@